Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Feasibility Study of Plasma-Activated Water As a Physical Therapy to Induce Apoptosis in Melanoma Cancer Cells In-Vitro Publisher



Mahdikia H1, 2 ; Shokri B1, 3 ; Majidzadeha K2, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Laser and Plasma Research Institute, Shahid Beheshti University, Tehran, Iran
  2. 2. Tasnim Biotechnology Research Center (TBRC), AJA University of Medical Science, Tehran, Iran
  3. 3. Department of Applied Physics, Shahid Beheshti University, Tehran, Iran
  4. 4. Genetics Department, Breast Cancer Research Center (BCRC), Motamed Cancer Institute (MCI), ACECR, Tehran, Iran

Source: Iranian Journal of Pharmaceutical Research Published:2021


Abstract

Low-temperature plasma (LTP) has demonstrated great potential in biomedicine, especially in cancer therapy in-vivo and in-vitro. Plasma activated water (PAW) as an indirect plasma therapy is a significant source of reactive oxygen and nitrogen species (RONS) which play an important role in apoptosis induction in cancer cells. In this study, Helium (He) plasma jet operating in 0.75 W and 20 kHz as dissipated power and frequency, respectively, is used as the cold plasma source. The electrical, thermal, and spectroscopic properties of (He) plasma jet and pH as well as the conductivity and temperature of PAW samples, are investigated. The concentration of hydrogen peroxide (H2 O2), nitrite (NO2-) and nitrate (NO-), which are produced in water as long-lived 3 anticancer RONS, was measured 471.6, 7.9 and 93.5 μM, respectively after 6 min of plasma treatment. Alamar Blue and flow cytometry assays were employed to investigate the B16 F10 cancer metabolic activity and apoptosis. These data support that cold atmospheric plasma (CAP) can produce a certain concentration of anti-cancer agents in water and induce apoptosis in melanoma cancer cells due to RONSs via activating the caspase 3 pathway. © 2021, Briefland. All rights reserved.